Prognostic factors and adjuvant therapy in patients with uterine carcinosarcoma

被引:0
|
作者
Nemani, D. [1 ]
Yang, W. [1 ]
Mitra, N. [1 ]
Lin, L. L. [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.ijrobp.2007.07.221
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S120 / S120
页数:1
相关论文
共 50 条
  • [31] Adjuvant chemotherapy in patients with uterine carcinosarcoma: a review of clinical outcomes and considerations
    Ogasawara, Aiko
    Shintatni, Daisuke
    Sato, Sho
    Hasegawa, Kosei
    EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (11-12): : 247 - 255
  • [32] Adjuvant Radiochemotherapy of Uterine Carcinosarcoma in need of optimization
    Jiang, P.
    Marnitz, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (09) : 843 - 845
  • [33] MANAGEMENT OF UTERINE CARCINOSARCOMA: ROLE OF ADJUVANT CHEMOTHERAPY
    Cafforio, Alessia
    Maiorano, Brigida Anna
    Maiello, Evaristo
    Cormio, Gennaro
    Cicinelli, Ettore
    Loizzi, Vera
    Arezzo, Francesca
    Resta, Leonardo
    Serio, Gabriella
    Cazzato, Gerardo
    Falcicchio, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A189 - A189
  • [34] Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma
    Wu, TI
    Chang, TC
    Hsueh, S
    Hsu, KH
    Chou, HH
    Huang, HJ
    Lai, CH
    GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 166 - 172
  • [35] Uterine sarcomas: Prognostic factors, outcomes, and adjuvant radiotherapy
    Sampath, S.
    Schultheiss, T. E.
    Ryu, J.
    Wong, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S19 - S19
  • [36] Utilization of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma
    Wong, A. T.
    Schwartz, D.
    Lee, A.
    Shao, M.
    Han, P. Y.
    Schreiber, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E291 - E291
  • [37] Single Institution Experience of the Effect of Adjuvant Radiation on Outcomes for Patients with Uterine Carcinosarcoma
    Tobillo, R.
    Grace, H.
    Martin, K. Sykes
    Ali, N.
    Patel, A. B., Jr.
    Patel, P. R.
    Shelton, J. W.
    Remick, J. S.
    Eng, T. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E549 - E549
  • [38] Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study
    Versluis, Marco A. C.
    Piesticker, Cindy
    van der Aa, Maaike A.
    de Bruyn, Marco
    Hollema, Harry
    Nijman, Hans W.
    ONCOLOGY, 2018, 95 (02) : 100 - 108
  • [39] Clinical outcomes of adjuvant radiation therapy and prognostic factors in early stage uterine cervical cancer
    Kim, Hyun Ju
    Rhee, Woo Joong
    Choi, Seo Hee
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Kim, Gwi Eon
    Kim, Yong Bae
    RADIATION ONCOLOGY JOURNAL, 2015, 33 (02): : 126 - 133
  • [40] Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma
    McEachron, Jennifer
    Heyman, Taryn
    Shanahan, Lisa
    Tran, Van
    Friedman, Monica
    Gorelick, Constantine
    Economos, Katherine
    Singhal, Pankaj K.
    Lee, Yi-Chun
    Kanis, Marguax J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (07) : 1012 - 1017